.⁦@myESMO⁩ reco for NGS 1. Public health: NSCLC, cholangio, prostate, ovarian Kc: ✅ + TMB in 5 add cancers. Optional CRC 2. Clin res centers: any pt eligible for trial 3. pt centric (outside 1): ✅if pt aware of v low benefit and no cost /public HS Tweet added by FabriceAndre @FAndreMD

FabriceAndre

4 years

.⁦ @myESMO ⁩ reco for NGS 1. Public health: NSCLC, cholangio, prostate, ovarian Kc: ✅ + TMB in 5 add cancers. Optional CRC 2. Clin res centers: any pt eligible for trial 3. pt centric (outside 1): ✅if pt aware of v low benefit and no cost /public HS

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic...

Next-generation sequencing (NGS) allows sequencing of a high number of nucleotides in a short time frame at an affordable cost. While this technology has been widely implemented, there are no...

www.annalsofoncology.org

2

45

100

FabriceAndre

@FAndreMD

4 years

Huge work from @myESMO staff and all authors: ESCAT ranking done in main cancers, then reviewed externally. Three layers of recommendations instead of one. Assessment of the technology NGS and the way it s implemented (small vs large panels). Updates planned on a regular basis.

0

6

20

Dr Jérôme BARRIERE, MD.

@barriere_dr

4 years

@FAndreMD @myESMO Urgent need for reimbursement in France for molecular testing 1/ for compagnon tests 2/ for germinal tests such as BRCA 1 More than 50% of the cost paid by the health centers which cause inequity in the cancer care

0

Replies